Rallybio Announces CFO Jonathan Lieber To Transition To Part-Time Employment Effective September 15, Remaining CFO And Principal Financial Officer; Employment To Terminate Upon Closing Of Avenzo Therapeutics Business Combination

Benzinga Newsdesk www.benzinga.com Neutral 92.6%

Neg 0% Neu 92.6% Pos 0%

https://www.sec.gov/ix?doc=/Archives/edgar/data/0001739410/000119312526386511/d96849d8k.htm

Comments

No comments yet. Be the first!